Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 7539
Country/Region: Rwanda
Year: 2009
Main Partner: Public Health Institute
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $150,000

Funding for Sexual Prevention: Abstinence/Be Faithful (HVAB): $0

USAID/Rwanda has three continuing staff engaged through the Global Health Fellows Program, and will

support a fourth position in FY 2008. Funding for these positions is distributed in HVAB, HVOP, HTXD,

OHPS and HVMS. Continuing Fellows are an HIV/AIDS Prevention Advisor, a Logistics Advisor and a

Senior Technical Advisor in the Program Office. For FY 2008, EP Rwanda proposes to add a

GFATM/Donor Coordination Advisor to be located in the GFATM office.

New/Continuing Activity: Continuing Activity

Continuing Activity: 17063

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

17063 17063.08 U.S. Agency for Public Health 7539 7539.08 GHFP $200,000

International Institute

Development

Table 3.3.02:

Funding for Treatment: ARV Drugs (HTXD): $150,000

ACTIVITY UNCHANGED FROM FY 2008:

In FY 2009, PEPFAR will support a Commodity and Logistics Advisor position through USAID's Global

Health Fellows Program. This activity includes personnel costs, equipment and services to support

PEPFAR management.

New/Continuing Activity: Continuing Activity

Continuing Activity: 16773

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

16773 16773.08 U.S. Agency for Public Health 7539 7539.08 GHFP $150,000

International Institute

Development

Program Budget Code: 16 - HLAB Laboratory Infrastructure

Total Planned Funding for Program Budget Code: $5,402,948

Total Planned Funding for Program Budget Code: $0

Program Area Narrative:

PEPFARs FY 2009 laboratory strategy builds on a tiered national laboratory system for creating sustainable infrastructure to

support care and treatment of HIV-infected patients. The funding from FY 2008 is providing support and technical assistance to

four key GOR institutions: 1) National Reference Laboratory (NRL); 2) University Teaching Hospital of Butare (CHUB); 3)

University Teaching Hospital of Kigali (CHUK); and 4) Kigali Health Institute (KHI). A five year strategic plan for the NRL was

established in 2006 and revised in 2008, and PEPFAR activities support that plan. The program is working with the Ministry of

Health (MOH) to further develop this strategic plan in cooperation with President's Malaria Initiative (PMI), Global Fund (GF),

World Health Organization (WHO) and other in-country stakeholders.

The national laboratory policy and strategic plan includes, but is not limited to the following activities: national laboratory policies

for minimal laboratory standards for each tier of the laboratory network; integration of clinical diagnostic laboratory services; plans

for harmonizing and maintaining laboratory equipment; inventory management and national forecasting of laboratory supplies,

reagents and test kits; plans for quality assurance programs; human capacity development; and standards for laboratory

information systems. Using this approach will provide a strategic vision and a better understanding of the function of laboratory

network, appropriate coordination of funding and a dedication of resources for increasing laboratory infrastructure where the

greatest needs exist. The NRL will coordinate all partners' activities within the laboratory network.

In FY 2009, PEPFAR will support NRL to strengthen linkages in the national tiered laboratory system. This includes laboratories,

in the national system that are linked from NRL to regional sites to district hospital sites to primary care site laboratories. NRL

supports 318 PMTCT, 315 VCT and 209 ART sites. The laboratory is comprised of more than 400 health centers, 42 district

hospitals, numerous private laboratories and 5 regional laboratories and 2 university teaching laboratories. NRL will continue to

improve the following infrastructure systems: financial, coordinated procurement, overall quality assurance, laboratory networks

and referrals, and laboratory information systems. NRL will continue to support human capacity development through specialized

training and ongoing technical assistance with special emphasis in FY 2009 on new CD4 count technologies suitable for primary

care, new HIV test technologies, training non-laboratory personnel to perform rapid HIV testing using finger prick method of blood

collection and new lab technicians for OI diagnosis and continue to improve the HIV prevention, care and treatment, TB and

malaria quality control programs.

The early infant diagnosis (EID) program currently supports 126 PMTCT sites to collect dried blood spots (DBS) from children

born to HIV-infected mothers. In FY 2009, the program will be scaled up to support a total of 178 PMTCT sites. In FY 2009, the

program will train 200 nurses and laboratory staff in DBS collection, in addition to laboratory technicians to support the

continuation of scale up of infant testing.

The USG will fund the laboratory coalition partners (Association of Public Health Laboratories (APHL), American Society for

Clinical pathology (ASCP), and the American Society for Microbiology (ASM) to support the NRL. These partners will provide

technical assistance to NRL to develop procedures and standards, to obtain international laboratory accreditation and to

implement OI and STI diagnostic assays. ASCP will be engaged in developing human capacity through curriculum improvements

to standardize in-service training materials and to expand support for pre-service training of laboratory technicians at KHI. ASM in

cooperation with Columbia ICAP will partner to work closely with NRL to improve TB culture laboratories and to strengthen TB and

malaria QA/QC. ASM will also work to improve the laboratory support for the diagnosis of OIs and STIs. Consultants will also be

identified who can provide technical assistance for better management of the tiered laboratory system.

In FY 2009, PEPFAR will continue to support sustainable laboratory systems by providing TA for training in OI diagnosis with

emphasis on MDR and extra pulmonary TB and parasitic infections at CHUB, CHUK and NRL. NRL will provide training in new

techniques to support program evaluation and surveillance and molecular virology techniques for HIV drug resistance surveillance

at five regional clinical diagnostic laboratories. The USG will continue to support long-term technical positions at the NRL to

assure quality HIV-related laboratory services through training and day-to-day mentorship of NRL staff. The USG will also

continue bolstering management and financial capacity at the NRL by maintaining the long-term laboratory management advisor

position and supporting improvements to the data management system for tracking specimens and reporting functions. In FY

2009, PEPFAR will support priority basic program evaluations, such as an evaluation of HIV rapid testing algorithms to support

provider initiated testing by non-lab personnel, an evaluation of simple technologies for CD4 and CD4% testing, and in-country

validation of rapid cryptococcal antigen testing.

In FY 2009, SCMS with assistance from the NRL will be responsible for the procurement of all laboratory commodities purchased

by PEPFAR through direct support to CAMERWA for the procurement, storage and distribution of all medicines, equipment and

laboratory supplies. This consolidated approach to procurement will increase cost savings and improve efficiencies in

procurement and distribution of commodities. It also supports building infrastructure within the country to support distribution of

laboratory commodities. SCMS will also take over the support of the CPDS and logistics management activities to ensure smooth

functioning of the CPDS system, quality data for quantification and strong communication between districts and CAMERWA.

Given a strong willingness to develop a highly functional national network, the USG is working with NRL to establish standard

practices which will facilitate more efficient delivery of services.

Table 3.3.16:

Funding for Health Systems Strengthening (OHSS): $0

New/Continuing Activity: Continuing Activity

Continuing Activity: 17120

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

17120 17120.08 U.S. Agency for Public Health 7539 7539.08 GHFP $43,578

International Institute

Development

Table 3.3.18:

Funding for Management and Operations (HVMS): $0

Noted April 24, 2008: Budget cut to fund required M&S adjustment, and to partially fund position to be filled

through another mechanism.

USAID/Rwanda has three continuing staff hired through the Global Health Fellows Program, and will a

fourth position will be added in FY 2008. Funding for these positions is distributed in HVAB, HVOP, HTXD,

OHPS and HVMS. The funding for each of these positions is spread across no more than three technical

areas. Continuing Fellows are an HIV/AIDS Prevention Advisor, a Logistics Advisor and a Senior Technical

Advisor in the Program Office. In FY 2008, EP proposes to add a GFATM/Donor Coordination Advisor to

be located in the GFATM office.

New/Continuing Activity: Continuing Activity

Continuing Activity: 16772

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

16772 16772.08 U.S. Agency for Public Health 7539 7539.08 GHFP $50,000

International Institute

Development

Table 3.3.19: